Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Class I/II recalls would require in-store patient notification under Shays/Dodd bill.

This article was originally published in The Tan Sheet

Executive Summary

OTC RECALL IN-STORE NOTIFICATION WOULD BE REQUIRED UNDER SHAYS/DODD BILL for Class I and Class II recalls involving all over-the-counter drug products sold in pharmacies. Retail outlets that only sell OTC products also could be required to display recall notices under the bill. The measure would require pharmacies to notify patients in writing when a prescription drug or device they purchased is subject to a Class I or Class II recall.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088217

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel